404 results on '"Kjellén, Elisabeth"'
Search Results
2. Dose-volume relationships of planned versus estimated delivered radiation doses to pelvic organs at risk and side effects in patients treated with salvage radiotherapy for recurrent prostate cancer
3. A prospective phase II study of prostate-specific antigen-guided salvage radiotherapy and 68Ga-PSMA-PET for biochemical relapse after radical prostatectomy – The PROPER 1 trial
4. Primary tumor volume and prognosis for patients with p16-positive and p16-negative oropharyngeal squamous cell carcinoma treated with radiation therapy
5. Ultra-hypofractionated radiotherapy for prostate cancer including seminal vesicles in the target volume: a treatment-planning study based on the HYPO-RT-PC fractionation schedule
6. Adaptive sequential plan-on-plan optimization during prostate-specific antigen response guided radiotherapy of recurrent prostate cancer
7. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial
8. PSA decay during salvage radiotherapy for prostate cancer as a predictor of disease outcome – 5 year follow-up of a prospective observational study
9. No Increased Cardiac Mortality or Morbidity of Radiation Therapy in Breast Cancer Patients After Breast-Conserving Surgery: 20-Year Follow-up of the Randomized SweBCGRT Trial
10. Erectile Dysfunction and Absorbed Dose to Penile Base Structures in a Randomized Trial Comparing Ultrahypofractionated and Conventionally Fractionated Radiation Therapy for Prostate Cancer
11. Distribution of Locoregional Breast Cancer Recurrence in Relation to Postoperative Radiation Fields and Biological Subtypes
12. 11: Register data on long-term morbidity after prostate ultra-hypofractionation in the HYPO-RT-PC trial
13. Differences in health related quality of life in the randomised ARTSCAN study; accelerated vs. conventional radiotherapy for head and neck cancer. A five year follow up
14. Anti- or pro-proliferation – Conditional options for TGF-α and cetuximab in head and neck squamous cell carcinoma
15. Haematological toxicity in adult patients receiving craniospinal irradiation – Indication of a dose-bath effect
16. MR and CT data with multiobserver delineations of organs in the pelvic area—Part of the Gold Atlas project
17. Qualitative interpretation of PET scans using a Likert scale to assess neck node response to radiotherapy in head and neck cancer
18. Results from a prospective, randomised study on (accelerated) preoperative versus (conventional) postoperative radiotherapy in treatment of patients with resectable squamous cell carcinoma of the oral cavity : The ARTSCAN 2 study
19. The anti-tumour effect of cisplatin and ifosfamide on xenografted squamous cell carcinoma of the head and neck is schedule-dependent
20. Additional file 1 of Primary tumor volume and prognosis for patients with p16-positive and p16-negative oropharyngeal squamous cell carcinoma treated with radiation therapy
21. Results from a prospective, randomised study on (accelerated) preoperative versus (conventional) postoperative radiotherapy in treatment of patients with resectable squamous cell carcinoma of the oral cavity – The ARTSCAN 2 study
22. Differences in Estimates of Cisplatin-Induced Cell Kill in vitro between Colorimetric and Cell Count/Colony Assays
23. Weight loss and body mass index in relation to aspiration in patients treated for head and neck cancer: a long-term follow-up
24. A prospective study of positron emission tomography for evaluation of neck node response 6 weeks after radiotherapy in patients with head and neck squamous cell carcinoma
25. Autocrine epidermal growth factor receptor ligand production and cetuximab response in head and neck squamous cell carcinoma cell lines
26. The quality assurance process for the ARTSCAN head and neck study – A practical interactive approach for QA in 3DCRT and IMRT
27. Epidermal growth factor receptor status and persistent activation of Akt and p44/42 MAPK pathways correlate with the effect of cetuximab in head and neck and colon cancer cell lines
28. Long-Term Risk of Hip Complications After Radiation Therapy for Prostate Cancer: A Dose-Response Study
29. Target definition in radiotherapy of prostate cancer using magnetic resonance imaging only workflow
30. COVID-19 Concerns Among Old Age Psychiatric In- and Out-Patients and the Employees Caring for Them, a Preliminary Study
31. Altered fractionation diminishes importance of tumor volume in oropharyngeal cancer: Subgroup analysis of ARTSCAN‐trial
32. Substantial intrinsic variability in chemoradiosensitivity of newly established anaplastic thyroid cancer cell-lines
33. Chemorefractory Rhabdomyosarcoma Treated with Radiotherapy, Bevacizumab, Statins and Surgery and Maintenance with Bevacizumab and Chemotherapy
34. FDG-PET in cervical cancer: staging, re-staging and follow-up
35. In vitro radiosensitization by oxaliplatin and 5-fluorouracil in a human colon cancer cell line
36. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer : 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial
37. DNA Ploidy, S-Phase Fraction and Associations with 2-18F-Fluoro-Deoxy-2-D-Glucose Positron Emission Tomography Findings Before and During Therapy of Head and Neck Squamous Cell Carcinoma
38. A Systematic Overview of Radiation Therapy Effects in Non-Small Cell Lung Cancer
39. Research and Development of Radiation Therapy in Clinical Routines
40. Early experience of long-term radiotherapy (RT) combined with oxaliplatin, 5-FU and leucovorin (FLOX) in locally advanced rectal cancer (LARC)
41. Cell-line-specific stimulation of tumor cell aggressiveness by wound healing factors – a central role for STAT3
42. Characterization of a Novel Breast Carcinoma Xenograft and Cell Line Derived from a BRCA1 Germ-Line Mutation Carrier
43. Palliative short-course hypofractionated radiotherapy followed by chemotherapy in esophageal adenocarcinoma: the phase II PALAESTRA trial
44. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial
45. The effect on the small bowel of 5-FU and oxaliplatin in combination with radiation using a microcolony survival assay
46. Comparison of cisplatin sensitivity and the 18F fluoro-2-deoxy 2 glucose uptake with proliferation parameters and gene expression in squamous cell carcinoma cell lines of the head and neck
47. Palliative short-course hypofractionated radiotherapy followed by chemotherapy in esophageal adenocarcinoma: the phase II PALAESTRA trial.
48. Comparative treatment planning study for mediastinal Hodgkin’s lymphoma: impact on normal tissue dose using deep inspiration breath hold proton and photon therapy
49. E-learning programs in oncology : a nationwide experience from 2005 to 2014
50. Active Transport of Nicotinamide and the Adenine Moiety of NAD by Metabolically Controlled NAD Catabolism
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.